2010 Hong Kong Reference Framework for Hypertension Care for ...

Module 7Drug Treatment for People with HypertensionReference:1. Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of differentblood-pressure-lowering regimens on major cardiovascular events: results of prospectivelydesignedoverviews of randomised trials. Lancet. 2003; 362(9395):1527-35.2. Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH, et al. Successand predictors of blood pressure control in diverse North American settings: TheAntihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).J Clin Hypertens (Greenwich). 2002;4(6):393-404.3. Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, Grimm RH, Jr., et al. BaselineCharacteristics and Early Blood Pressure Control in the CONVINCE Trial. Hypertension.2001; 37(1):12-8.4. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, andother blood-pressure-lowering drugs: results of prospectively designed overviews ofrandomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet.2000;356(9246):1955-64.5. U.S. Department of Health and Human Services. The seventh report of the Joint NationalCommittee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.[Internet]. Bethesda, MD: U.S. Department of Health and Human Services; 2004. Availablefrom: http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf6. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascularmorbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertensionstudy (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003.7. Major outcomes in high-risk hypertensive patients randomized to angiotensin-convertingenzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-97.8. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensinconverting-enzymeinhibitor, ramipril, on cardiovascular events in high-risk patients.The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):145-53.9. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressurelowering regimen among 6,105 individuals with previous stroke or transient ischaemicattack. Lancet. 2001;358(9287):1033-41.HK Reference Framework for Hypertension Care for Adults in Primary Care Settings6